Low molecular weight heparin treatment of acute moderate and severe pancreatitis: A randomized, controlled, open-label study

Creative Commons License

Tozlu M., Kayar Y., İNCE A. T., Baysal B., Şentürk H.

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.30, no.1, pp.81-87, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 1
  • Publication Date: 2019
  • Doi Number: 10.5152/tjg.2018.18583
  • Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.81-87
  • Keywords: Severe acute pancreatitis, moderately severe acute pancreatitis, low molecular weight heparin, pancreatic necrosis, complication, INFLAMMATION, ENCEPHALOPATHY, ACTIVATION
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background/Aims: Acute pancreatitis (AP) runs a moderately severe and severe course in 20%-30% of cases. The purpose of the present study was to determine the effect of low molecular weight heparin (LMWH) for the prevention of pancreatic necrosis (PN) in moderately severe and severe AP (MSAP).